PMI Buys Israeli Marijuana Company for $650 Million

BusinessPMI by Jacky Yin
Jul.19.2023
PMI Buys Israeli Marijuana Company for $650 Million
Philip Morris International (PMI) is in the process of acquiring an Israeli medical marijuana company Syqe Medical for up to $650 million. Syqe's main product is said to be a medical marijuana-measured dose inhaler for pain relief.

On July 18, Israeli media outlet Calcalistech reported that Philip Morris International (PMI) is in the process of acquiring Israeli medical marijuana company Syqe Medical for up to $650 million. Syqe's main product is a medical marijuana-measured dose inhaler for pain relief.

 

菲莫国际加码医用大麻市场? 或以6.5亿美元收购以色列大麻公司
Syqe product | calcalistech

 

Acquisition of all shares for USD $650 million

According to the report, PMI will first invest $120 million to support the Syqe inhaler's approval by the U.S. Food and Drug Administration (FDA). If approval is granted through clinical trials, PMI will go on to purchase all remaining shares of the Israeli company for $650 million.

 

The deal will be carried out through PMI's subsidiary Vectura, which specializes in the inhaler space. PMI had acquired Vectura for £1 billion in 2021 as part of its strategy to transition to smoke-free world.

 

It is public information that in 2016, PMI made a $20 million investment in Syqe.

 

A number of independent patented technologies

If the acquisition goes through, it will be one of the biggest deals in the Israeli med-tech sector in recent years; and if it reaches a valuation of $650 million, Syqe will become one of the top 10 cannabis companies in the world.

 

Founded in 2011 by Perry Davidson, who still serves as CEO, Syqe holds around 120 patents, and its main innovations are the use of the raw inflorescence of the cannabis plant rather than processed products, and the ability to accurately measure the dosage given to patients.

 

It's worth noting that total investment in the company to date is $80 million, with Davidson holding more than 10 percent of the shares.

 

Currently, more than 80% of medical marijuana consumers use smoking products such as cigarettes and e-cigarettes, leading to potential overdoses, and Syqe's inhaler provides relief without the need for an overdose, avoiding the "psychoactive effect".

 

FDA approval is a key milestone

In the past, these inhalers were marketed and distributed through the Israeli pharmaceutical company Teva. Recently, however, Syqe has chosen to market independently and has entered into partnership agreements with the Ministry of Defense and Meuhedet HMO.

 

Syqe's primary target market is outside of Israel, and its FDA approval is a key milestone. According to the report, PMI will play an important role in getting Syqe through FDA approval. If successful, Syqe will be the first company in the world to receive FDA approval for the use of raw cannabis inflorescences as medicine.

 

PMI is one of the world's largest cigarette manufacturers with a market capitalization of $154 billion. In recent years, PMI has launched a new tobacco transformation strategy, and today more than one-third of its revenue comes from smokeless products, including heated tobacco products like IQOS.

 

According to PMI, the medical marijuana market is worth $24 billion, growing at a 15% annual rate through 2030. The wellness market, which includes cannabis-based tranquilizers and sleep aids, is estimated to be worth an additional $4 billion, with an 8% growth rate.

 

Syqe's inhaler is currently available in Israel and Australia, which are relatively small markets. The Israeli market is estimated at only NIS 100 million (approximately USD $27.5 million) per year, serving approximately 50,000 medical marijuana patients.

 

Reference:

【1】Philip Morris acquiring Cannabis inhaler developer Syqe Medical for up to $650 million

*The content excerpted or reproduced in this article comes from a third-party, and the copyright belongs to the original media and author. If any infringement is found, please contact us to delete it. Any entity or individual wishing to forward the information, please contact the original author and refrain from forwarding directly from here.

Nielsen Report: Rampant Illegal Cigarette Trade in Malaysia Causes Annual Tax Loss of Up to RM5 Billion
Nielsen Report: Rampant Illegal Cigarette Trade in Malaysia Causes Annual Tax Loss of Up to RM5 Billion
According to data from the internationally renowned market research firm NielsenIQ, the illegal cigarette trade in Malaysia results in tax losses of RM5 billion (USD 1.1 billion) annually. Illegal products account for 54.6% of the market, with Johor, Selangor, and Sabah identified as smuggling hotspots. Customs authorities have successfully seized 6 million smuggled cigarettes.
Jun.16 by 2FIRSTS.ai
2Firsts Interviews Harm Reduction Policy Expert Jeannie Cameron: WHO’s Rejection of Harm Reduction Is Undermining Global Tobacco Control
2Firsts Interviews Harm Reduction Policy Expert Jeannie Cameron: WHO’s Rejection of Harm Reduction Is Undermining Global Tobacco Control
As part of its GFN media partnership, 2Firsts spoke with FCTC expert Jeannie Cameron, who warns that the WHO’s rejection of harm reduction is leading global tobacco control efforts off course.
Jun.18
Exhibition Watch | Brands like RELX、Firstunion and HQD Showcase Aluminum Alloy E-Cigarettes
Exhibition Watch | Brands like RELX、Firstunion and HQD Showcase Aluminum Alloy E-Cigarettes
The Dubai E-Cigarette Expo was held at the World Trade Center from June 18-20. A 2Firsts survey revealed that multiple brands, including Firstunion, RELX, and HQD, showcased e-cigarettes made from aluminum alloy.
Jun.24
Product | FASTA Nicotine Pouches Launch in U.S. with 22 Pouches per Can and 2 Nicotine Strengths
Product | FASTA Nicotine Pouches Launch in U.S. with 22 Pouches per Can and 2 Nicotine Strengths
A new product, FASTA NICOTINE POUCHES, has recently launched on U.S. vape distributor websites. Available in 6mg and 15mg nicotine strengths and six flavors, each can contains 22 pouches. Produced by UK-based REAZEN TECH LIMITED and marketed as “100% Made in Europe,” the product is currently priced at around $4.99.
May.14 by 2FIRSTS.ai
Malta Health Authority Issues Warning on Nicotine Pouches, Plans Inclusion in Future Tobacco Control Strategy
Malta Health Authority Issues Warning on Nicotine Pouches, Plans Inclusion in Future Tobacco Control Strategy
Malta’s health authorities warn of the dangers of nicotine pouches as several European countries initiate bans.
Jul.08
Saudi Arabia's New Regulation: Grocery Stores Banned from Selling Cigarettes, E-Cigarettes, and Hookahs
Saudi Arabia's New Regulation: Grocery Stores Banned from Selling Cigarettes, E-Cigarettes, and Hookahs
Saudi Arabia's Ministry of Municipal and Rural Affairs has issued a new regulation prohibiting grocery stores from selling tobacco, fresh foods like dates, e-cigarettes, and hookahs. Existing stores are given a 6-month period to make necessary adjustments.
Jun.25 by 2FIRSTS.ai